On January 24, Cialis (601127SH) disclosed the performance forecast of its 2023 annual report, and it is expected to achieve operating income of 35.5 billion yuan to 36.5 billion yuan in 2023, an increase of 4% year-on-year09% to 702%；It is estimated that the net profit attributable to the parent company will be -2.7 billion yuan to -2.1 billion yuan, an improvement of 29 percent year-on-year5%-45.1%。
Although it still faces a large loss for the whole year, from the fourth quarter alone, Cialis is expected to finally achieve profitability.
According to the previously disclosed third quarter report of 2023, the net profit attributable to the parent company in the first three quarters of last year was about -2.3 billion yuan. According to this calculation, in the fourth quarter of last year, the net profit attributable to the parent company of Cialis is expected to be between -400 million yuan and 200 million yuan. If the final performance can fall on the upper edge of the ** range, it means that Cialis will achieve a single-quarter profit.
Data map: Wenjie M9
Obviously, the hot sales of the M7 model in the fourth quarter of last year have brought a huge boost to the performance of Cialis.
According to the production and sales report, the sales of new energy vehicles reached 42,141 in December last year, a year-on-year increase of 15321%；Among them, Cialis Automobile sold 31,490 vehicles in December, a year-on-year increase of 21003%。In addition, Huawei's data shows that in December, the delivery of one model of the M7 reached 20,611 units.
The M9 released at the end of last year also received great attention, and it was set to exceed 30,000 units in 7 days on the market. It is reported that the annual sales target of the Wenjie brand in 2024 is 600,000 units, with an average monthly sales of more than 50,000 units, which is expected to challenge the sales champion position of new car companies.
According to this speculation, the performance of Cialis in 2024 is expected to continue to improve.
However, it is worth noting that the 2023 performance of Cialis also contains a large non-recurring profit and loss.
The performance forecast shows that the non-net profit deducted by Cialis in 2023 will be -5 billion yuan to -4.6 billion yuan, which means that its non-recurring profit and loss may exceed 2 billion yuan.
In the first three quarters of this year, the non-recurring profit and loss of Cialis was 7200 million yuan, of which the main items are the income from the disposal of illiquid assets, as well as the ** subsidy included in the current profit and loss.
If this large part of the revenue is lost in the future, it remains to be seen whether Cialis can truly achieve profitability.